Imatinib-induced cytogenetic remission in chronic eosinophilic leukaemia

Intern Med J. 2006 Aug;36(8):537-8. doi: 10.1111/j.1445-5994.2006.01122.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzamides
  • Chronic Disease
  • Cytogenetic Analysis*
  • Eosinophilia / blood
  • Eosinophilia / drug therapy*
  • Eosinophilia / genetics
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Remission Induction

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate